Cellosaurus logo
expasy logo

Cellosaurus LNCaP (CVCL_0395)

[Text version]
Cell line name LNCaP
Synonyms LNCAP; LNCap; Ln-Cap; LNCaP-RPCI; Lymph Node Carcinoma of the prostate
Accession CVCL_0395
Resource Identification Initiative To cite this cell line use: LNCaP (RRID:CVCL_0395)
Comments Group: Space-flown cell line (cellonaut).
Part of: ENCODE project common cell types; tier 3.
Population: Caucasian.
Doubling time: ~60 hours (DSMZ=ACC-256).
Microsatellite instability: Instable (MSI) (PubMed=23671654).
Omics: Genomics; ChIP-seq; H3K4me3.
Omics: Genomics; Whole exome sequencing.
Omics: Proteomics.
Omics: Proteomics; PTM; Glycoproteome.
Omics: Proteomics; PTM; GPI-anchored proteins.
Omics: Proteomics; PTM; Phosphorylation.
Omics: Proteomics; PTM; Phosphorylation; Quantitative.
Omics: Proteomics; Virome.
Omics: Transcriptomics; Microarray.
Omics: Transcriptomics; RNAseq.
Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
Omics: Variations; Array-based CGH.
Omics: Variations; SNP array analysis.
Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
Sequence variations
  • Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (PubMed=22213130).
  • Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from child cell line LNCaP clone FGC).
  • Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from child cell line LNCaP clone FGC).
  • Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (PubMed=9090379).
  • Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=14518029).
HLA typing Source: PubMed=26589293
Class I
HLA-AA*01:01,02:01
HLA-BB*08:01,37:04
HLA-CC*06:02,07:01
Class II
HLA-DQDQB1*05:01,05:01
HLA-DRDRB1*10:01,10:01
Disease Prostate carcinoma (NCIt: C4863)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_E1LT (HyCyte LNCaP KO-hFOXA1)CVCL_E3HT (HyCyte LNCaP-Luc)CVCL_M126 (LNCaP 104-S)
CVCL_M129 (LNCaP C-33)CVCL_4783 (LNCaP C4)CVCL_M132 (LNCaP C5)
CVCL_1379 (LNCaP clone FGC)CVCL_M133 (LNCaP M)CVCL_4793 (LNCaP-abl)
CVCL_3872 (LNCaP-CL1)CVCL_8986 (LNCaP-CR)CVCL_V260 (LNCaP-CS10)
CVCL_RA57 (LNCaP-EnzR)CVCL_L160 (LNCaP-LN1)CVCL_5J24 (LNCaP-luc2)
CVCL_9U27 (LNCaP-OM)CVCL_C0RR (LNCaP-PDR1)CVCL_C0RS (LNCaP-PDR2)
CVCL_L164 (LNCaP-Pro1)CVCL_5J03 (LNCaP-Red-FLuc)CVCL_4792 (LNCaP-Rf)
CVCL_F0L9 (LNCaPR)CVCL_D575 (LNGK9)CVCL_UD76 (LREX')
CVCL_RW50 (MR42D)CVCL_RW51 (MR42F)CVCL_RW52 (MR49C)
CVCL_RW53 (MR49F)
Sex of cell Male
Age at sampling 50Y
Category Cancer cell line
STR profile Source(s): CCRID=1101HUM-PUMC000040; CLS=300265; DSMZ=ACC-256; PubMed=11416159; PubMed=14518029; PubMed=25877200

Markers:
AmelogeninX (CLS=300265)
X,Y (CCRID=1101HUM-PUMC000040; DSMZ=ACC-256; PubMed=11416159; PubMed=14518029; PubMed=25877200)
CSF1PO10,11
D2S133816 (DSMZ=ACC-256)
16,17 (CCRID=1101HUM-PUMC000040)
D3S135816
D5S81811,12 (CCRID=1101HUM-PUMC000040; CLS=300265; DSMZ=ACC-256; PubMed=14518029)
11,12,13 (PubMed=25877200)
D7S8208.1,9.1,10.3 (CCRID=1101HUM-PUMC000040; PubMed=25877200)
9,11 (PubMed=14518029)
9.1,10.3 (CLS=300265; DSMZ=ACC-256)
D8S117912,13,14 (DSMZ=ACC-256; PubMed=11416159)
12,14 (CCRID=1101HUM-PUMC000040; CLS=300265; PubMed=14518029; PubMed=25877200)
D13S31710,11,12,13 (PubMed=14518029)
10,12 (CCRID=1101HUM-PUMC000040; CLS=300265; DSMZ=ACC-256; PubMed=25877200)
D16S53911
D18S519,11,12 (CCRID=1101HUM-PUMC000040)
11,12 (CLS=300265; DSMZ=ACC-256; PubMed=14518029; PubMed=25877200)
D19S43313.2,15 (CCRID=1101HUM-PUMC000040)
14,15 (DSMZ=ACC-256)
D21S1128,29,31.2 (PubMed=25877200)
29,31.2 (CLS=300265)
29,31.2,32.2 (DSMZ=ACC-256; PubMed=11416159)
29,32.2 (CCRID=1101HUM-PUMC000040; PubMed=14518029)
FGA19,20 (CCRID=1101HUM-PUMC000040; CLS=300265; PubMed=14518029; PubMed=25877200)
19,20,21 (DSMZ=ACC-256; PubMed=11416159)
Penta D12,12.4
Penta E12,16 (CLS=300265; DSMZ=ACC-256)
16 (PubMed=25877200)
TH019
TPOX8,9
vWA16,18

Run an STR similarity search on this cell line
Web pages Info; -; -; https://lncap.com/
Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/LNCaP_Crawford_protocol.pdf
Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/l/cell-lines-detail-136.html
Info; Wikipedia; -; https://en.wikipedia.org/wiki/LNCaP
Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/prostate-cancer-xenograft/lncap-xenograft-model/
Provider; CH3 Biosystems; 940002; https://ch3biosystems.com/shop/lncap/
Publications

CLPUB00410
Julius Stanislaw Horoszewicz, Susan S. Leong, Tsann Ming Chu, L. Zew Wajsman, Mendel Friedman, Lawrence D. Papsidero, Untae Kim, Lee S. Chai, Surabhi Kakati, Suresh K. Arya, Avery Aba Sandberg;
The LNCaP cell line -- a new model for studies on human prostatic carcinoma.
(In book chapter) Models for prostate cancer; Murphy, Gerald Patrick (eds.); pp.115-132; Alan R. Liss; New York; USA (1980)

PubMed=6831420
Julius Stanislaw Horoszewicz, Susan S. Leong, Elzbieta Kawinski, James P. Karr, Hannah Rosenthal, Tsann Ming Chu, Edwin A. Mirand, Gerald Patrick Murphy;
LNCaP model of human prostatic carcinoma.
Cancer Res. 43:1809-1818(1983)

PubMed=3518877; DOI=10.3109/07357908609038260
Jorgen Fogh;
Human tumor lines for cancer research.
Cancer Invest. 4:157-184(1986)

PubMed=3335022
Michael C. Alley, Dominic A. Scudiero, Anne Monks, Miriam L. Hursey, Maciej J. Czerwinski, Donald L. Fine, Betty Jane Abbott, Joseph G. Mayo, Robert H. Shoemaker, Michael R. Boyd;
Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.
Cancer Res. 48:589-601(1988)

PubMed=2734981; DOI=10.1007/BF00262025
Josee J. Konig, Eric Kamst, Anne Hagemeijer, Johannes C. Romijn, Julius Stanislaw Horoszewicz, Fritz H. Schroder;
Cytogenetic characterization of several androgen responsive and unresponsive sublines of the human prostatic carcinoma cell line LNCaP.
Urol. Res. 17:79-86(1989)

PubMed=8687134
Prakash K. Pandalai, Mary Jo Pilat, Kosuki Yamazaki, Harmesh Naik, Kenneth James Pienta;
The effects of omega-3 and omega-6 fatty acids on in vitro prostate cancer growth.
Anticancer Res. 16:815-820(1996)

PubMed=9018337; DOI=10.1002/(SICI)1097-0045(19970101)30:1<58::AID-PROS9>3.0.CO;2-H
Mukta M. Webber, Diana Bello, Salmaan T.A. Quader;
Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications Part 2. Tumorigenic cell lines.
Prostate 30:58-64(1997)

PubMed=9090379; DOI=10.1038/ng0497-356
Peter A. Steck, Mark A. Pershouse, Samar A. Jasser, Wai-Kwan Alfred Yung, Huai Lin, Azra Hadi Ligon, Lauren A. Langford, Michelle L. Baumgard, Thomas Hattier, Thaylon Davis, Cheryl Frye ...Show all 15 authors... , Rong Hu, Bradley Swedlund, David H.-F. Teng, Sean V. Tavtigian; Show fewer authors
Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.
Nat. Genet. 15:356-362(1997)

PubMed=9460501; DOI=10.1016/S0165-4608(97)00060-5
Nina N. Nupponen, Eija-Riitta Hyytinen, Anne H. Kallioniemi, Tapio Visakorpi;
Genetic alterations in prostate cancer cell lines detected by comparative genomic hybridization.
Cancer Genet. Cytogenet. 101:53-57(1998)

PubMed=10702678; DOI=10.1159/000015432
Yi Pan, Soili Kytola, Filip Farnebo, Na Wang, Weng-Onn Lui, Nina N. Nupponen, Jorma J. Isola, Tapio Visakorpi, Ulf S.R. Bergerheim, Catharina Larsson;
Characterization of chromosomal abnormalities in prostate cancer cell lines by spectral karyotyping.
Cytogenet. Cell Genet. 87:225-232(1999)

PubMed=10972993; DOI=10.1002/1098-2744(200008)28:4<236::AID-MC6>3.0.CO;2-H
Christine Rauh-Adelmann, Kin-Mang Lau, Nari Sabeti, John P. Long, Samuel C. Mok, Shuk-Mei Ho;
Altered expression of BRCA1, BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines.
Mol. Carcinog. 28:236-246(2000)

PubMed=11135431; DOI=10.1002/1098-2264(2000)9999:9999<::AID-GCC1076>3.0.CO;2-E
Joan Aurich-Costa, Anne Vannier, Eric Gregoire, Frederique Nowak, Dorra Cherif;
IPM-FISH, a new M-FISH approach using IRS-PCR painting probes: application to the analysis of seven human prostate cell lines.
Genes Chromosomes Cancer 30:143-160(2001)

PubMed=11172901; DOI=10.1016/S0165-4608(00)00339-3
Jonathan C. Strefford, Debra M. Lillington, Bryan D. Young, R. Timothy D. Oliver;
The use of multicolor fluorescence technologies in the characterization of prostate carcinoma cell lines: a comparison of multiplex fluorescence in situ hybridization and spectral karyotyping data.
Cancer Genet. Cytogenet. 124:112-121(2001)

PubMed=11304728; DOI=10.1002/pros.1045
Adrie van Bokhoven, Marileila Varella-Garcia, Christopher T. Korch, Daphne Hessels, Gary J. Miller;
Widely used prostate carcinoma cell lines share common origins.
Prostate 47:36-51(2001)

PubMed=11414198; DOI=10.1007/s004320000207
Harald Lahm, Sabine Andre, Andreas Hoeflich, Jurgen R. Fischer, Bernard Sordat, Herbert Kaltner, Eckhard Wolf, Hans-Joachim Gabius;
Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures.
J. Cancer Res. Clin. Oncol. 127:375-386(2001)

PubMed=11416159; DOI=10.1073/pnas.121616198; PMCID=PMC35459
John R.W. Masters, Jim A. Thomson, Bernadette Daly-Burns, Yvonne A. Reid, Wilhelm Gerhard Dirks, Phil Packer, Lorraine H. Toji, Tadao Ohno, Hideyuki Tanabe, Colin Francis Arlett, Lloyd R. Kelland ...Show all 16 authors... , Maureen Harrison, Arvind K. Virmani, Timothy H. Ward, Karen L. Ayres, Paul G. Debenham; Show fewer authors
Short tandem repeat profiling provides an international reference standard for human cell lines.
Proc. Natl. Acad. Sci. U.S.A. 98:8012-8017(2001)

PubMed=12606952; DOI=10.1038/sj.onc.1206247
Jeremy Clark, Sandra Edwards, Andrew Feber, Penny Flohr, Megan John, Ian Giddings, Susan Crossland, Michael Rudolf Stratton, Richard Wooster, Colin Campbell, Colin S. Cooper;
Genome-wide screening for complete genetic loss in prostate cancer by comparative hybridization onto cDNA microarrays.
Oncogene 22:1247-1252(2003)

PubMed=12725112; DOI=10.1385/1-59259-372-0:21
Pamela J. Russell, Elizabeth A. Kingsley;
Human prostate cancer cell lines.
Methods Mol. Med. 81:21-39(2003)

PubMed=14518029; DOI=10.1002/pros.10290
Adrie van Bokhoven, Marileila Varella-Garcia, Christopher T. Korch, Widya U. Johannes, E. Erin Smith, Heidi L. Miller, Steven K. Nordeen, Gary J. Miller, M. Scott Lucia;
Molecular characterization of human prostate carcinoma cell lines.
Prostate 57:205-225(2003)

CLPUB00698
Adrie van Bokhoven;
Models for prostate cancer. Molecular characterization and critical appraisal of human prostate carcinoma cell lines.
Thesis PhD (2004); Katholieke Universiteit Nijmegen; Nijmegen; Netherlands

PubMed=15162376; DOI=10.1002/pros.20031
Alvin Y. Liu, Kristen D. Brubaker, Young Ah Goo, Janna E. Quinn, Sabine Kral, Carrie M. Sorensen, Robert Louis Vessella, Arie S. Belldegrun, Leroy Edward Hood;
Lineage relationship between LNCaP and LNCaP-derived prostate cancer cell lines.
Prostate 60:98-108(2004)

PubMed=15486987; DOI=10.1002/pros.20158
Hong-Juan Zhao, Young Kim, Pei Wang, Jacques Lapointe, Robert Tibshirani, Jonathan R. Pollack, James D. Brooks;
Genome-wide characterization of gene expression variations and DNA copy number changes in prostate cancer cell lines.
Prostate 63:187-197(2005)

PubMed=22213130; DOI=10.1002/pros.22480
Lien Spans, Zeynep Kalender Atak, Filip Van Nieuwerburgh, Dieter Deforce, Evelyne Lerut, Stein Aerts, Frank Claessens;
Variations in the exome of the LNCaP prostate cancer cell line.
Prostate 72:1317-1327(2012)

PubMed=22278370; DOI=10.1074/mcp.M111.014050; PMCID=PMC3316730
Tamar Geiger, Anja Wehner, Christoph Schaab, Jurgen Cox, Matthias Mann;
Comparative proteomic analysis of eleven common cell lines reveals ubiquitous but varying expression of most proteins.
Mol. Cell. Proteomics 11:M111.014050-M111.014050(2012)

PubMed=23671654; DOI=10.1371/journal.pone.0063056; PMCID=PMC3646030
Yu-Heng Lu, T. David Soong, Olivier Elemento;
A novel approach for characterizing microsatellite instability in cancer cells.
PLoS ONE 8:e63056.1-e63056.10(2013)

PubMed=24587179; DOI=10.1371/journal.pone.0090002; PMCID=PMC3938550
Lien Spans, Christine Helsen, Liesbeth Clinckemalie, Thomas Van den Broeck, Stefan Prekovic, Steven Joniau, Evelyne Lerut, Frank Claessens;
Comparative genomic and transcriptomic analyses of LNCaP and C4-2B prostate cancer cell lines.
PLoS ONE 9:e90002.1-e90002.8(2014)

PubMed=24618588; DOI=10.1371/journal.pone.0091433; PMCID=PMC3950186
Alexey L. Chernobrovkin, Roman A. Zubarev;
Detection of viral proteins in human cells lines by xeno-proteomics: elimination of the last valid excuse for not testing every cellular proteome dataset for viral proteins.
PLoS ONE 9:e91433.1-e91433.6(2014)

PubMed=25485619; DOI=10.1038/nbt.3080
Christiaan Klijn, Steffen Durinck, Eric W. Stawiski, Peter M. Haverty, Zhao-Shi Jiang, Han-Bin Liu, Jeremiah Degenhardt, Oleg Mayba, Florian Gnad, Jin-Feng Liu, Gregoire Pau ...Show all 30 authors... , Jens Reeder, Yi Cao, Kiran Mukhyala, Suresh K. Selvaraj, Ma-Mie Yu, Gregory J. Zynda, Matthew J. Brauer, Thomas D. Wu, Robert Clifford Gentleman, Gerard Manning, Robert L. Yauch, Richard Bourgon, David Stokoe, Zora Modrusan, Richard M. Neve, Frederic J. de Sauvage, Jeffrey Settleman, Somasekar Seshagiri, Ze-Min Zhang; Show fewer authors
A comprehensive transcriptional portrait of human cancer cell lines.
Nat. Biotechnol. 33:306-312(2015)

PubMed=25877200; DOI=10.1038/nature14397
Ma-Mie Yu, Suresh K. Selvaraj, May M.Y. Liang-Chu, Sahar Aghajani, Matthew Busse, Jean Yuan, Genee Lee, Franklin V. Peale, Christiaan Klijn, Richard Bourgon, Joshua S. Kaminker, Richard M. Neve;
A resource for cell line authentication, annotation and quality control.
Nature 520:307-311(2015)

PubMed=26256267; DOI=10.1074/mcp.M115.047928; PMCID=PMC4597149
Punit Shah, Xiang-Chun Wang, Wei-Ming Yang, Shadi Toghi Eshghi, Shi-Sheng Sun, Naseruddin Hoti, Li-Jun Chen, Shu-Ang Yang, Jered Pasay, Abby Rubin, Hui Zhang;
Integrated proteomic and glycoproteomic analyses of prostate cancer cells reveal glycoprotein alteration in protein abundance and glycosylation.
Mol. Cell. Proteomics 14:2753-2763(2015)

PubMed=26589293; DOI=10.1186/s13073-015-0240-5; PMCID=PMC4653878
Jelle Scholtalbers, Sebastian Boegel, Thomas Bukur, Marius Byl, Sebastian Goerges, Patrick Sorn, Martin Loewer, Ugur Sahin, John C. Castle;
TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.
Genome Med. 7:118.1-118.7(2015)

PubMed=26972028; DOI=10.1016/j.jprot.2016.03.008
Yusuke Masuishi, Yayoi Kimura, Noriaki Arakawa, Hisashi Hirano;
Identification of glycosylphosphatidylinositol-anchored proteins and omega-sites using TiO2-based affinity purification followed by hydrogen fluoride treatment.
J. Proteomics 139:77-83(2016)

PubMed=27036029; DOI=10.18632/oncotarget.8456; PMCID=PMC5041979
Steven Kregel, James L. Chen, Westin Tom, Venkatesh Krishnan, Jacob Kach, Hannah Brechka, Tim B. Fessenden, Masis Isikbay, Gladell Pador Paner, Russell Z. Szmulewitz, Donald J. Vander Griend;
Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer.
Oncotarget 7:26259-26274(2016)

PubMed=27141528; DOI=10.1016/j.dib.2016.04.001; PMCID=PMC4838930
Yusuke Masuishi, Yayoi Kimura, Noriaki Arakawa, Hisashi Hirano;
Data for identification of GPI-anchored peptides and omega-sites in cancer cell lines.
Data Brief 7:1302-1305(2016)

PubMed=29194687; DOI=10.1002/pros.23459; PMCID=PMC5768451
Michael V. Fiandalo, John H. Wilton, Krystin M. Mantione, Carol Wrzosek, Kristopher M. Attwood, Yue Wu, James Larue Mohler;
Serum-free complete medium, an alternative medium to mimic androgen deprivation in human prostate cancer cell line models.
Prostate 78:213-221(2018)

PubMed=29233929; DOI=10.1158/0008-5472.CAN-17-1924; PMCID=PMC5983359
Aaron Marks Horning, Yao Wang, Che-Kuang Lin, Anna D. Louie, Rohit R. Jadhav, Chia-Nung Hung, Chiou-Miin Wang, Chun-Lin Lin, Nameer B. Kirma, Michael A. Liss, Addanki P. Kumar ...Show all 18 authors... , Lu-Zhe Sun, Zhi-Jie Liu, Wei-Ting Chao, Qian-Ben Wang, Victor X. Jin, Chun-Liang Chen, Tim Hui-Ming Huang; Show fewer authors
Single-cell RNA-seq reveals a subpopulation of prostate cancer cells with enhanced cell-cycle-related transcription and attenuated androgen response.
Cancer Res. 78:853-864(2018)

PubMed=29660373; DOI=10.1016/j.bbagen.2018.04.012
Zahia Touat-Hamici, Anne-Laure Bulteau, Juliusz Bianga, Helene Jean-Jacques, Joanna Szpunar, Ryszard Lobinski, Laurent Chavatte;
Selenium-regulated hierarchy of human selenoproteome in cancerous and immortalized cells lines.
Biochim. Biophys. Acta 1862:2493-2505(2018)

PubMed=29739788; DOI=10.1158/1078-0432.CCR-18-0410; PMCID=PMC6125187
Renee de Leeuw, Christopher McNair, Matthew J. Schiewer, Neermala Poudel-Neupane, Lucas J. Brand, Michael A. Augello, Zhen Li, Larry C. Cheng, Akihiro Yoshida, Sean M. Courtney, Edward Starr Hazard ...Show all 17 authors... , Gary Hardiman, Maha H. Hussain, John Alan Diehl, Justin M. Drake, William Kevin Kelly, Karen E. Knudsen; Show fewer authors
MAPK reliance via acquired CDK4/6 inhibitor resistance in cancer.
Clin. Cancer Res. 24:4201-4214(2018)

PubMed=30787054; DOI=10.1158/1055-9965.EPI-18-1132; PMCID=PMC6548687
Stanley Eugene Hooker Jr., Leanne Woods-Burnham, Madhavi Bathina, Stacy Lloyd, Priyatham Gorjala, Ranjana Mitra, Larisa Nonn, K. Sean Kimbro, Rick Antonius Kittles;
Genetic ancestry analysis reveals misclassification of commonly used cancer cell lines.
Cancer Epidemiol. Biomarkers Prev. 28:1003-1009(2019)

PubMed=35502546; DOI=10.1158/0008-5472.CAN-22-1065; PMCID=PMC9153264
Cory Abate-Shen, Francisca Nunes de Almeida;
Establishment of the LNCaP cell line -- the dawn of an era for prostate cancer research.
Cancer Res. 82:1689-1691(2022)

PubMed=38892296; DOI=10.3390/ijms25116111; PMCID=PMC11172770
Erica L. Beatson, Emily N. Risdon, Giulia C. Napoli, Douglas K. Price, Cindy H. Chau, William Douglas Figg Sr.;
Genomic characterization of preclinical prostate cancer cell line models.
Int. J. Mol. Sci. 25:6111.1-6111.19(2024)

Cross-references
Cell line collections (Providers) CCTCC; GDC0283
CCTCC; GDC0284
CLS; 300265
DSMZ; ACC-256
Cell line databases/resources CLO; CLO_0007365
CLO; CLO_0037116
MCCL; MCC:0000290
CLDB; cl3243
cancercelllines; CVCL_0395
CCRID; 1101HUM-PUMC000040
DSMZCellDive; ACC-256
LINCS_LDP; LCL-1298
Lonza; 109
TOKU-E; 3599
Anatomy/cell type resources BTO; BTO_0001321
Biological sample resources BioSample; SAMN03472386
CRISP screens repositories BioGRID_ORCS_Cell_line; 182
Chemistry resources ChEMBL-Cells; CHEMBL3307965
ChEMBL-Targets; CHEMBL612518
PharmacoDB; LNCAP_850_2019
PubChem_Cell_line; CVCL_0395
Encyclopedic resources Wikidata; Q6459234
Experimental variables resources EFO; EFO_0002071
Gene expression databases ArrayExpress; E-MTAB-2706
GEO; GSE99795
GEO; GSM91927
GEO; GSM142457
GEO; GSM142458
GEO; GSM383948
GEO; GSM383953
GEO; GSM482669
GEO; GSM525800
GEO; GSM784790
GEO; GSM816634
GEO; GSM816637
GEO; GSM844579
GEO; GSM945240
GEO; GSM945282
GEO; GSM1022672
GEO; GSM1029460
GEO; GSM1029461
GEO; GSM1029462
GEO; GSM1029463
GEO; GSM1029464
GEO; GSM1029465
GEO; GSM1029466
GEO; GSM1029467
GEO; GSM1374622
GEO; GSM1374626
GEO; GSM2069518
GEO; GSM2069519
GEO; GSM2069520
GEO; GSM2069521
GEO; GSM2069522
GEO; GSM2069523
GEO; GSM2069524
GEO; GSM2069525
GEO; GSM2650017
GEO; GSM2650018
GEO; GSM2650019
GEO; GSM2650020
GEO; GSM2650021
GEO; GSM2650022
GEO; GSM3145602
GEO; GSM3145720
Polymorphism and mutation databases Cosmic; 704848
Cosmic; 721368
Cosmic; 721555
Cosmic; 755298
Cosmic; 759895
Cosmic; 801348
Cosmic; 850413
Cosmic; 850745
Cosmic; 850821
Cosmic; 869155
Cosmic; 918500
Cosmic; 920967
Cosmic; 921047
Cosmic; 922553
Cosmic; 923955
Cosmic; 943176
Cosmic; 948076
Cosmic; 949248
Cosmic; 1028648
Cosmic; 1028701
Cosmic; 1066237
Cosmic; 1070886
Cosmic; 1071481
Cosmic; 1071906
Cosmic; 1075275
Cosmic; 1172626
Cosmic; 1176618
Cosmic; 1330909
Cosmic; 1556120
Cosmic; 1689708
Cosmic; 1995486
Cosmic; 2537792
Cosmic; 2580128
Cosmic; 2585151
Cosmic; 2585228
Cosmic; 2621168
Cosmic; 2651770
Cosmic; 2669169
Cosmic; 2816221
IARC_TP53; 21076
Progenetix; CVCL_0395
Proteomic databases PRIDE; PXD000953
PRIDE; PXD000985
PRIDE; PXD002107
PRIDE; PXD002395
PRIDE; PXD003105
PRIDE; PXD003262
PRIDE; PXD006561
PRIDE; PXD032264
Sequence databases EGA; EGAS00001000610
Entry history
Entry creation04-Apr-2012
Last entry update14-Aug-2025
Version number45